These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 29353491)
1. High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose. Murphy RA; Hatlen TJ; Moosa MS AIDS Res Hum Retroviruses; 2018 May; 34(5):399-403. PubMed ID: 29353491 [TBL] [Abstract][Full Text] [Related]
2. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial. Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259 [TBL] [Abstract][Full Text] [Related]
8. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Sloan D; Dlamini S; Paul N; Dedicoat M Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697 [TBL] [Abstract][Full Text] [Related]
9. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426 [TBL] [Abstract][Full Text] [Related]
10. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774 [TBL] [Abstract][Full Text] [Related]
11. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Loyse A; Thangaraj H; Easterbrook P; Ford N; Roy M; Chiller T; Govender N; Harrison TS; Bicanic T Lancet Infect Dis; 2013 Jul; 13(7):629-37. PubMed ID: 23735626 [TBL] [Abstract][Full Text] [Related]
12. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients. Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072 [TBL] [Abstract][Full Text] [Related]
14. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis. Milefchik E; Leal MA; Haubrich R; Bozzette SA; Tilles JG; Leedom JM; McCutchan JA; Larsen RA Med Mycol; 2008 Jun; 46(4):393-5. PubMed ID: 18415850 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Mayanja-Kizza H; Oishi K; Mitarai S; Yamashita H; Nalongo K; Watanabe K; Izumi T; Ococi-Jungala ; Augustine K; Mugerwa R; Nagatake T; Matsumoto K Clin Infect Dis; 1998 Jun; 26(6):1362-6. PubMed ID: 9636863 [TBL] [Abstract][Full Text] [Related]
16. Responding to the evidence for improved treatment for cryptococcal meningitis in resource-limited settings. Milani B; Ford N S Afr Med J; 2012 Mar; 102(4):196-7. PubMed ID: 22464494 [No Abstract] [Full Text] [Related]
17. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068 [TBL] [Abstract][Full Text] [Related]
18. High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis. Zhao HZ; Wang RY; Wang X; Jiang YK; Zhou LH; Cheng JH; Huang LP; Harrison TS; Zhu LP BMC Infect Dis; 2018 Dec; 18(1):643. PubMed ID: 30541454 [TBL] [Abstract][Full Text] [Related]
19. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania. Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E; Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550 [TBL] [Abstract][Full Text] [Related]
20. A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis. Jackson AT; Nussbaum JC; Phulusa J; Namarika D; Chikasema M; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; van der Horst C; Harrison TS AIDS; 2012 Jul; 26(11):1363-70. PubMed ID: 22526517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]